Kiran Dole - Concepedia

Author

Kiran Dole

Novartis (United States)

Also Known As

K DOLE, K. Dole, Kiran DOLE, Kiran Dole

Publications

901

Citations

H-Index

Concepts

All Affiliations

Novartis (United States)Hospital for Sick Children University at Buffalo, State University of New York Novartis (Switzerland)University of Toronto

About

Kiran Dole is an author at Novartis (United States) specializing in medicine, immunology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	355
2	Health Sciences	1	1	30
3	Biochemistry	1	1	30
4	Cell Biology	1	1	31
5	Cellular Therapies	1	1	31

Kiran Dole

Publications

874

Citations

H-Index

Page 1

	Year	Citations
Mutation analysis of the BRCA2 gene in 49 site–specific breast cancer families Catherine M. Phelan, Johnathan M. Lancaster, Patricia N. Tonin, Nature Genetics Breast OncologyGeneticsBrca2 GeneBreast CancerMutation Analysis	1996	255
O‐glycan biosynthesis in human colorectal adenoma cells during progression to cancer Fabienne Vavasseur, Kiran Dole, Jimmy Yang, European Journal of Biochemistry	1994	133
Synthesis of <i>O</i>-glycan core 3: Characterization of UDP-GlcNAc: GalNAc-R β3-<i>N</i>-acetyl-glucosaminyltransferase activity from colonic mucosal tissues and lack of the activity in human cancer cell lines Fabienne Vavasseur, Jimao Yang, Kiran Dole, Glycobiology	1995	80
Inhibition of fatty acid synthase with <scp>FT‐4101</scp> safely reduces hepatic de novo lipogenesis and steatosis in obese subjects with non‐alcoholic fatty liver disease: Results from two early‐phase randomized trials Carine Beysen, Patricia Schroeder, Eric Wu, Diabetes Obesity and Metabolism	2020	51
Clinical disposition, metabolism and<i>in vitro</i>drug–drug interaction properties of omadacycline Jimmy Flarakos, Yancy Du, Helen Gu, Xenobiotica	2016	49
Vildagliptin, a Novel Dipeptidyl Peptidase IV Inhibitor, Has No Pharmacokinetic Interactions With the Antihypertensive Agents Amlodipine, Valsartan, and Ramipril in Healthy Subjects Yanling He, Monica Ligueros‐Saylan, Gangadhar Sunkara, The Journal of Clinical Pharmacology	2007	43
Evaluation of the potential for steady-state pharmacokinetic interaction between vildagliptin and simvastatin in healthy subjects Surya Ayalasomayajula, Kiran Dole, Yanling He, Current Medical Research and Opinion	2007	43
Engraftment and tumorigenesis of HTLV-1 transformed T cell lines in SCID/bg and NOD/SCID mice Yingxian Liu, Kiran Dole, James R. L. Stanley, Leukemia Research Nod/scid MiceCell TherapyT-regulatory CellImmunologyCell Transplantation	2002	31
Ketoconazole Increases Fingolimod Blood Levels in a Drug Interaction via CYP4F2 Inhibition John M. Kovarik, Kiran Dole, Gilles‐Jacques Rivière, The Journal of Clinical Pharmacology Healthy SubjectsCyp4f2 InhibitionPharmacotherapyFingolimod Blood LevelsExperimental Pharmacology	2009	30
Sex differences in cyclosporine pharmacokinetics and<scp>ABCB</scp>1 gene expression in mononuclear blood cells in African American and Caucasian renal transplant recipients Kathleen M. Tornatore, Daniel A. Brazeau, Kiran Dole, The Journal of Clinical Pharmacology	2013	28

Page 1